NCT01441752View on ClinicalTrials.gov

Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

TCM

three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe.

DRUG

placebo

three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe，with the same color, smell ，taste weight and package

Trial Locations (2)

200032

ShanghaiUTCM, Shanghai

Xuling, Shanghai

All Listed Sponsors
lead

xuling

OTHER

NCT01441752 - Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients | Biotech Hunter | Biotech Hunter